AKEBIA THERAPEUTICS, INC. Inventory, LIFO Reserve, Period Charge
AKEBIA THERAPEUTICS, INC. (AKBA) reported Inventory, LIFO Reserve, Period Charge of $1.58 million for the 12-month period ending 2023-12-31, per its 10-K filed 2024-03-14.
Discontinued › Cash Flow › Other Cash Flow Items
us-gaap:InventoryLIFOReservePeriodCharge · last filed 2024-03-14
- AKEBIA THERAPEUTICS, INC. inventory, lifo reserve, period charge for fiscal 2023 was $1.58M, a 94.78% decline from fiscal 2022.
- AKEBIA THERAPEUTICS, INC. inventory, lifo reserve, period charge for fiscal 2022 was $30.24M.
| Period end | Inventory, LIFO Reserve, Period Charge 12 month |
|---|---|
| 2023-12-31 | $1.58M 10-K · filed 2024-03-14 |
| 2022-12-31 | $30.24M 10-K · filed 2024-03-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Lyell Immunopharma, Inc. (LYEL) | United States | $0.248B | -1.32 |
| Pyxis Oncology, Inc. (PYXS) | United States | $0.244B | |
| Greenwich LifeSciences, Inc. (GLSI) | United States | $0.267B | -15.02 |
| Entrada Therapeutics, Inc. (TRDA) | United States | $0.243B | -1.73 |
| Cue Biopharma, Inc. (CUE) | United States | $0.243B | -1.01 |
| MACROGENICS INC (MGNX) | United States | $0.242B | -20.11 |
| Mereo BioPharma Group plc (MREO) | $0.269B | -9.41 | |
| Camp4 Therapeutics Corp (CAMP) | United States | $0.240B | -2.12 |
| Sionna Therapeutics, Inc. (SION) | United States | $0.236B | -20.37 |
| SIGA TECHNOLOGIES INC (SIGA) | United States | $0.234B | -93.33 |